Medicines information provided by pharmaceutical representatives: A comparative study in Australia and Malaysia

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Othman, Noordin ^a,b   Vitry, Agnes I ^a   Roughead, Elizabeth E ^a   Ismail, Shaiful B ^c   Omar, Khairani ^d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^c SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^d DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADULT; ARTICLE; AUSTRALIA; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG INDUSTRY; FEMALE; GENERAL PRACTITIONER; HUMAN; INFORMATION DISSEMINATION; MALAYSIA; MALE; MIDDLE AGED; PUBLIC RELATIONS; QUESTIONNAIRE; STATISTICAL MODEL;

ADULT; AUSTRALIA; CHI-SQUARE DISTRIBUTION; DRUG INDUSTRY; FEMALE; GENERAL PRACTITIONERS; HUMANS; INFORMATION DISSEMINATION; INTERINSTITUTIONAL RELATIONS; LINEAR MODELS; MALAYSIA; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES;

EID: 78649470201     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-743     Document Type: Article

References (38)

1. Intercontinental Marketing Services. http://www.imshealth.com - - Either ISSN or Journal title must be supplied.
2. Content-Analysis of Drug-Detailing by Pharmaceutical Representatives. E Hemminki, Medical Education 1977 11 3 865343
3. The Accuracy of Drug Information from Pharmaceutical Sales Representatives. MG Ziegler P Lew BC Singer, JAMA 1995 273 16 1296 1298 10.1001/jama.273.16.1296 7715044
4. Self-regulatory codes of conduct: Are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? EE Roughead AL Gilbert KJ Harvey, International Journal of Health Services 1998 28 2 269 279 10.2190/B81X-4A53-TY5M-C2HR 9595344
5. What information do physicians receive from pharmaceutical representatives? J Lexchin, Canadian Family Physician 1997 43 941 945 9154366
6. Commercial Information on Drugs - Confusing the Physician. E Hemminki, Journal of Drug Issues 1988 18 2 245 257
7. 15 years of monitoring and one simple conclusion: don't expect sales representatives to help improve healthcare quality. Prescrire International 2006 15 84
8. Medicines Australia. Code of Conduct Edition 15. http://www. medicinesaustralia.com.au/pages/page254.asp - - Either ISSN or Journal title must be supplied.
9. Regulation of advertising of therapeutic goods in Australia. http://www.tga.gov.au/docs/html/advreg.htm - - Either ISSN or Journal title must be supplied.
10. Pharmaceutical Associations of Malaysia. Code of conduct for prescription (ethical) products. http://www.phama.org.my - - Either ISSN or Journal title must be supplied.
11. Pharmaceutical Associations of Malaysia. Job opportunities. http://www.phama.org.my/index.cfm?&menuid=21 - - Either ISSN or Journal title must be supplied.
12. Pharmaceutical Associations of Malaysia. http://www.phama.org.my/ - - Either ISSN or Journal title must be supplied.
13. World Health Organisation. Medicines Policy. http://www.who.int/ medicines/areas/policy/en/ - - Either ISSN or Journal title must be supplied.
14. Department of Health and Ageing. The National Medicines Policy. http://www.health.gov.au/internet/main/publishing.nsf/Content/ nmp-objectives-index.htm - - Either ISSN or Journal title must be supplied.
15. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. SS Hasan SI Ahmed NI Bukhari WCW Loon, Complementary Therapies in Clinical Practice 2009 15 3 152 157 10.1016/j.ctcp.2009.02.003 19595416
16. Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia. ZUD Babar MIM Ibrahim H Singh NI Bukahri A Creese, PLoS Med 2007 4 3 82 10.1371/journal.pmed.0040082 17388660
17. Evidence-based decision on medical technologies in Asia Pacific: Experiences from India, Malaysia, Philippines, and Pakistan. U Thatte S Hussain M De Rosas-Valera MA Malik, Value in Health 2009 12 SUPPL 3 20586975
18. Medicines information in medical journal advertising in Australia, Malaysia and the United States. N Othman A Vitry EE Roughead, Southern Med Review 2010 3 1
19. Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States. N Othman A Vitry E Roughead, BMC Public Health 2010 10 1 294 10.1186/1471-2458-10-294 20509953
20. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study. B Montgomery P Mansfield G Spurling A Ward, BMC Public Health 2008 8 1 167 10.1186/1471-2458-8-167 18492241
21. Healthy Skepticism. http://healthyskepticism.org/harm.php - - Either ISSN or Journal title must be supplied.
22. Promotion Overdose. http://www.choice.com.au/Reviews-and-Tests/Food-and- Health/General-health/Medicines/Promotion-overdo$e/Page/Introduction. aspx - - Either ISSN or Journal title must be supplied.
23. Australian Competition and Consumer Commission. http://www.accc.gov.au/ content/index.phtml/itemId/142 - - Either ISSN or Journal title must be supplied.
24. Therapeutic Guidelines Limited. http://www.tg.org.au/index.php?sectionid= 1 - - Either ISSN or Journal title must be supplied.
25. Malaysian Pharmaceutical Industry Outlook 2008. http://www.frost.com/ prod/servlet/market-insight-top.pag?docid=126369590 - - Either ISSN or Journal title must be supplied.
26. Consumers International. Drugs, doctors and dinners. http://www. consumersinternational.org/media/311707/drugs,%20doctors%20and%20dinners.pdf - - Either ISSN or Journal title must be supplied.
27. Performance of sales representatives in France: still bad. Prescrire International. Prescrire International, 2003 12 66 153 154 - - Either ISSN or Journal title must be supplied.
28. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives. D Strang M Gagnon W Molloy M Bedard P Darzins E Etchells W Davidson, Annals (Royal College Of Physicians And Surgeons Of Canada) 1996 29 8 (Print) 474 478 12380577
29. The Australian General Practice Network. http://www.agpn.com.au/home - - Either ISSN or Journal title must be supplied.
30. The Malaysian Medical Association. http://www.mma.org.my/ - - Either ISSN or Journal title must be supplied.
31. Department of Health and Ageing. Schedule of Pharmaceutical Benefits. http://www.pbs.gov.au/html/home - - Either ISSN or Journal title must be supplied.
32. Performance of sales representatives in France:still bad. Prescrire International 2003 12 66
33. National Prescribing Service. http://www.nps.org.au/ - - Either ISSN or Journal title must be supplied.
34. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. MA Gagnon J Lexchin, PLoS Medicine/Public Library of Science 2008 5 1 3
35. Does drug promotion adversely influence doctors' abilities to make the best decisions for patients? J Jureidini P Mansfield, Australasian Psychiatry 2001 9 2 95 99 10.1046/j.1440-1665.2001.00313.x (Pubitemid 32631497)
36. National Prescribing Service. Evaluation Report No.10-December 2007. http://www.nps.org.au/research-and-evaluation/publications/reports/reports/ report-10 - Either ISSN or Journal title must be supplied.
37. Academic detailing to improve anti hypertensive prescribing patterns. D Siegel J Lopez J Meier MK Goldstein S Lee BJ Brazill MS Matalka, American Journal of Hypertension 2003 16 6 10.1016/S0895-7061(03)00060-8 12799103
38. Error reduction: Academic detailing as a method to reduce incorrect prescriptions. J Shaw P Harris G Keogh L Graudins E Perks PS Thomas, European Journal of Clinical Pharmacology 2003 59 8-9 697 699 10.1007/s00228-003-0683-2 14566443